Inthedesign
randomisedcontrouledtriaL studvingtheeffects ofmetformin+ repaglinidecompared
tometformin monotherapy in patientswithtvpe2diabetes meulitus,to what doesthe'powerofthe
study' refer?
Thechancethat aclinicalty sianificamt difference wiu beobserved
Theprobability of astatistically sianificanttreatmenteffect if thetruetreatmemtdifferenceisata
prespecifiedlevet
The probability ofatype-2error
Theprobability ofrejectinqthenuL hypothesis thatthetreatmentshavethe sameeffect
Thesizeoftreatmentdifferencethatthetriaucanbeexpectedtodetect
@1MINENDOCRINE
